Rachel Rosovsky

@PERTConsortium @VIVAPhysicians @RosovskyRachel Superb study published in @CircAHA. First RCT in PE in more than a decade. Big step forward!

@RosovskyRachel Presents STORM-PE RCT Results at VIVA 2025 @PERTConsortium @roblookstein | @Angiologist hemostasistoday.com/voices/rachel-… #Anticoagulation #DeepVenousThrombosis #DVT #Health #Hematology #Hemostasis #STORM_PE #HemostasisToday #Medicine #PERTConsortium #VIVA2025 #PulmonaryEmbolism #Thrombosis #VenousThrombosis #MedEd #MedX

#JustPublished: STORM-PE RCT Primary Outcomes @roblookstein @RosovskyRachel @sahilparikhmd @angiologist @KNagarshethMD ahajrnls.org/47EvaEU

Thank you @Pertconsortium for partnering with Penumbra on this trial.

Breaking news! @RosovskyRachel announced the PE- Storm Trial first and secondary results just published.

Thrilled on behalf of all the STORM-PE investigators and patients to share these groundbreaking results. Thank you Circ for simultaneous publication: ahajournals.org/doi/10.1161/CI…

Thank you Circ for simultaneous publication:ahajournals.org/doi/10.1161/CI…

Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Signific... prn.to/4qYWMOb

Thank you VIVA and honored to present our late breaking abstract, STORM-PE 90 days results showing earlier physiological recovery and improvement in 90 day functional status with MT + AC vs AC alone in intermediate high risk PE pts. Thank you Circ for simultaneous publication. #VIVA2025 @PERTConsortium

#VIVA25: Rachel Rosovsky outlines further results from the STORM-PE RCT with findings simultaneously published in @CircAHA @VIVAPhysicians

Live @TCTConference @crfheart amazing session today discussing the impact of the #STORM-PE data on the future of #PE care. Thank you @PenVascular for the support of the study.

Patients with acute intermediate-high-risk PE who undergo mechanical thrombectomy have a greater reduction in the RV/LV ratio at 48 hours than those treated with anticoagulation alone, according to results from the first-of-its-kind STORM-PE RCT. #TCT2025 tctmd.com/news/mechanica…

The first—and only—RCT proving anticoagulation (AC) works for PE was in 1960 with 73 patients. See how far we've come. At #VIVA2025, on behalf of #STORMPE team & in collaboration #PERTConsortium, I’ll present the first RCT comparing MT + AC vs AC alone for acute intermediate–high-risk PE. @PERTConsortium @roblookstein @stavroskonstan7 @IdoWeinberg @rchannick @sahilparikhmd johnmoriarty suhaildohad richarddavis

Live @TCTConference First podium presentation of the #STORM-PE trial!! First RCT of thrombectomy vs Anticoag ever!! Thank you to @crfheart @PenVascular @PERTConsortium for advancing the field

@PERTConsortium Join us today to learn about the PERC database and how you get involved.

Webinar today at noon! Join us for a deep dive into the PERC Database, the only quality assurance registry purpose built for pulmonary embolism. We'll cover onboarding, data entry, benchmarking, research applications, and more. Register Now: csavevents.zoom.us/webinar/regist…

Join us in San Diego for the PERT Consortium 2025 Scientific Symposium. Learn and network with experts from all over the world.

We want to learn from you! How do you evaluate heavy menstrual bleeding in patients on anticoagulation. Take our survey: redcap.link/f8v5m0si @CardioNerds @isth @ASH_hematology @PERTConsortium @thrombosisday @acweyand @bhwords @aswolberg @fnainle

How do you as a medical provider evaluate heavy menstrual bleeding in patients on anticoagulation? Foundation for Women & Girls w/Blood Disorders is interested in identifying ways to improve care for patients with menorrhagia through research survey. redcap.link/f8v5m0si

Join us tonight as our Trainee Council members present challenge PE cases from their institutions. Learn from these emerging leaders in the PE space. @FMaeWestMD @jameshorowitzmd @EricSecemskyMD @cardionerds @bhwords @JonnyMoriarty @drandrewsharp @GBarnesMD @klinelabs @DavidACohen3